Earnings
ADCT
28.29
-2.45%
-0.71
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
0.00
0.00
--
--
76.78M
140.30M
--
--
--
219.26M
--
-219.26M
-27.28M
--
584.00K
--
-245.96M
327.00K
-246.29M
--
-246.29M
-246.29M
--
--
-3.21
FY 2019-12-31
2.34M
2.34M
--
--
13.81M
106.28M
--
--
--
121.74M
--
-119.40M
1.84M
--
1.66M
--
-115.90M
582.00K
-116.48M
--
-116.48M
-116.48M
--
--
-1.52
FY 2018-12-31
1.14M
1.14M
--
--
8.60M
117.74M
--
--
--
127.08M
--
-125.94M
3.07M
--
--
--
-122.87M
224.00K
-123.10M
--
-123.10M
-123.10M
--
--
-1.60
FY 2017-12-31
1.80M
1.80M
--
--
7.81M
85.33M
--
--
--
93.47M
--
-91.67M
1.86M
--
--
--
-89.81M
48.00K
-89.86M
--
-89.86M
-89.86M
--
--
-1.17

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ADCT latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze ADC Therapeutics recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.